Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer

  1. Boyle, F.M.
  2. Smith, I.E.
  3. O'Shaughnessy, J.
  4. Ejlertsen, B.
  5. Buzdar, A.U.
  6. Fumoleau, P.
  7. Gradishar, W.
  8. Martin, M.
  9. Moy, B.
  10. Piccart-Gebhart, M.
  11. Pritchard, K.I.
  12. Lindquist, D.
  13. Amonkar, M.
  14. Huang, Y.
  15. Rappold, E.
  16. Williams, L.S.
  17. Wang-Silvanto, J.
  18. Kaneko, T.
  19. Finkelstein, D.M.
  20. Goss, P.E.
Revista:
European Journal of Cancer

ISSN: 1879-0852 0959-8049

Ano de publicación: 2015

Volume: 51

Número: 6

Páxinas: 685-696

Tipo: Achega congreso

DOI: 10.1016/J.EJCA.2015.02.005 GOOGLE SCHOLAR